和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

已收盘 01-15 16:08:10

14.530

+0.070

+0.48%

最高14.800	最低14.300	成交量198.01万
今开14.400	昨收14.460	日振幅3.46%
总市值126.12亿	流通市值126.12亿	总股本8.68亿
成交额2,877万	换手率0.23%	流通股本8.68亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":14.53,"timestamp":1768464490003,"preClose":14.46,"halted":0,"volume":1980054,"delay":0,"changeRate":0.004840940525587725,"floatShares":868000000,"shares":868000000,"eps":0.003616,"marketStatus":"已收盘","change":0.07,"latestTime":"01-15 16:08:10","open":14.4,"high":14.8,"low":14.3,"amount":28768614,"amplitude":0.034578,"askPrice":14.53,"askSize":1000,"bidPrice":14.42,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":0.661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768527000000},"marketStatusCode":5,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":14.46,"openAndCloseTimeList":[[1768440600000,1768449600000],[1768453200000,1768464000000]],"volumeRatio":0.328943,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2603262688","title":"【券商聚焦】华泰证券：超预期创新药BD带动板块共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2603262688","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603262688?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:57","pubTimestamp":1768438620,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，步入2026年以来，港股创新药交易不足两周，但已如该机构预期迎来开门红。港股创新药板块流动性大幅修复，且随着JPM医药峰会本周拉开序幕，中国BD交易持续超预期，相比去年同期有较大增长。该机构认为开年以来的流动性修复将带来一波明确的创新药β行情，该机构看好突破前高。外需型CXO在新分子需求的驱动下，业绩持续超预期，有望和创新药实现共振。该机构建议策略上优选中美估值差距较大的创新药资产相应公司；受益于新分子药物（多肽、寡核苷酸及ADC）的涌现，外需型CXO龙头凭借充沛的在手订单+强劲的漏斗效应，整体业绩已进入加速上升通道。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973256","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","BK1610","LU1719994722.HKD","LU0819121731.USD","SG9999004220.SGD","LU2476274308.USD","LU0140636845.USD","LU1688375341.USD","LU1979443071.USD","LU1226288170.HKD","BK1574","BK1588","LU1961090484.USD","06978","LU0516422952.EUR","LU0856984785.SGD","06185","09926","01093","LU0823426480.USD","LU2097828714.EUR","LU1303224171.USD","01877","06160","LU1960683339.HKD","LU0348825331.USD","SG9999002463.SGD","LU0348783233.USD","159992","01801","LU2328871848.SGD","02142","02616","LU1251922891.USD","IE00BZ08YR35.GBP","BK0028","LU1934453819.USD","09995","LU0348827113.USD","LU1993786604.SGD","LU0561508036.HKD","01177","IE00BPRC5H50.USD","09688","601688","LU2488822045.USD","LU1064131003.USD","LU0072913022.USD","BK1515","BK1161"],"gpt_icon":0},{"id":"2603632732","title":"每日卖空追踪 | 和铂医药-B 01月13日卖空量成交22.3万股，卖空比例为3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632732?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293027,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月13日，涨4.23%，卖空量成交22.3万股，较上一交易日减少60.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165241a71505f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165241a71505f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2603327496","title":"和铂医药-B01月13日获主力加仓614.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603327496","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603327496?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292121,"startTime":"0","endTime":"0","summary":"01月13日, 和铂医药-B股价涨4.23%，报收14.80元，成交金额1.0亿元，换手率0.80%，振幅6.90%，量比1.18。和铂医药-B今日主力资金净流入614.1万元，连续7日净流入，上一交易日主力净流入752.3万元。近一年数据显示，该股主力连续7日净流入后，次日上涨概率为100.00%，平均涨幅为5.08%。该股近5个交易日上涨20.55%，主力资金累计净流入2859.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4059.3万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161714a714e12d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161714a714e12d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2603540761","title":"每日卖空追踪 | 和铂医药-B 01月12日卖空量成交21.4万股，卖空比例为4.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603540761","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603540761?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206626,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月12日，涨1.43%，卖空量成交21.4万股，较上一交易日减少38.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164835a710c8eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164835a710c8eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1583","02142"],"gpt_icon":0},{"id":"2603540753","title":"和铂医药-B01月12日获主力加仓752.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603540753","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603540753?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205717,"startTime":"0","endTime":"0","summary":"01月12日, 和铂医药-B股价涨1.43%，报收14.20元，成交金额7223.8万元，换手率0.59%，振幅4.79%，量比0.88。和铂医药-B今日主力资金净流入752.3万元，连续6日净流入，上一交易日主力净流入144.4万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为40.00%，平均涨幅为4.94%。该股近5个交易日上涨14.04%，主力资金累计净流入2527.7万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3599.1万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112161753a710aac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112161753a710aac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2602156192","title":"中泰证券：维持和铂医药-B(02142)“买入”评级 MNC合作全面深化 平台价值加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2602156192","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602156192?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:33","pubTimestamp":1768181639,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中泰证券发布研报称，维持和铂医药-B“买入”评级，和铂医药凭借其全人源抗体技术平台，在2025年与阿斯利康、大冢、辉瑞、BMS等全球多家顶尖药企达成深度合作，已确立其作为全球创新抗体关键源头技术提供商的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600918","02142"],"gpt_icon":0},{"id":"2602884312","title":"【券商聚焦】华泰证券：开年以来的流动性修复有望提振创新药板块β","url":"https://stock-news.laohu8.com/highlight/detail?id=2602884312","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602884312?lang=zh_cn&edition=full","pubTime":"2026-01-09 08:58","pubTimestamp":1767920334,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，自9月港股创新药年内新高以来，港股创新药指数截止到年底回调24%，而同期美股生物科技指数XBI涨幅29%，NBI指数涨幅18%。XBI自4月底部反弹超过100%，大型MNC普遍自底部反弹30~50%，礼来市值首次突破万亿美金。步入新的一年，港股创新药迎来开门红。随着流动性修复及对外BD持续，以及JPM峰会、年报周期的BD旺季和数据披露高峰的到来，该机构认为开年以来的流动性修复有望提振创新药板块β，上涨趋势有望持续。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972900","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","LU0516422440.USD","LU1242518857.USD","BK0183","LU1960683339.HKD","BK1141","LU2148510915.USD","LU0501845795.SGD","LU0307460666.USD","LU0315179316.USD","LU0417516571.SGD","LU0588546209.SGD","LU2476274720.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU0043850808.USD","LU1152091168.USD","06185","06160","159992","LU1226287792.SGD","LU3063872942.SGD","02616","601688","BK0012","LU0516422952.EUR","BK1589","LU2097828805.USD","01177","LU1807302812.USD","IE0008369823.USD","09995","LU0561508036.HKD","LU2097828474.EUR","LU1979443071.USD","BK1500","LU0516423174.USD","LU0039217434.USD","09688","06978","01093","LU1328277881.USD","02142","09926","LU0502904849.HKD","LU1064131003.USD","02269","01877","01801","LU0067412154.USD"],"gpt_icon":0},{"id":"2601949398","title":"创新药“华山奖”企业奖36家入围名单公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2601949398","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601949398?lang=zh_cn&edition=full","pubTime":"2026-01-08 18:19","pubTimestamp":1767867540,"startTime":"0","endTime":"0","summary":"“医学界”与“同写意”共同发起的创新药“华山奖”企业奖入围名单公布，共36家企业入围。奖项旨在发现中国创新药价值医疗标杆，通过量化指标评选产生。奖项分三类：最佳领导型创新医药企业奖，要求企业具有卓越综合实力、深远行业影响力等，年药品销售收入在100亿元以上，百济神州、阿斯利康等12家企业入围；最佳成长型创新医药企业奖，要求企业展现出卓越成长潜力，年药品销售收入处于10亿-100亿元之间，信达生物、传奇生物等12家企业入围；最佳潜力型创新医药企业奖，要求企业展现出卓越创新能力，年药品销售收入在10亿元以下或未有商业化产品，和铂医药、科伦博泰生等2家企业（名单未完全列举）入围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108184317a4abbfff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108184317a4abbfff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1574","06160","06978","BK1161"],"gpt_icon":0},{"id":"2601398915","title":"每日卖空追踪 | 和铂医药-B 01月08日卖空量成交33.3万股，卖空比例为3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601398915?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861029,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月08日，涨6.41%，卖空量成交33.3万股，较上一交易日减少78.63%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164617a4ab4493&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164617a4ab4493&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02142","BK1161"],"gpt_icon":0},{"id":"2601398969","title":"和铂医药-B01月08日获主力加仓742.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601398969?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860134,"startTime":"0","endTime":"0","summary":"01月08日, 和铂医药-B股价涨6.41%，报收14.12元，成交金额1.5亿元，换手率1.18%，振幅10.55%，量比1.77。和铂医药-B今日主力资金净流入742.2万元，连续4日净流入，上一交易日主力净流入606.6万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为71.43%，平均涨幅为3.85%。该股近5个交易日上涨15.38%，主力资金累计净流入1604.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4141.0万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162020a4ab2a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162020a4ab2a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"1114259311","title":"港股异动 | 医药股走高，加科思-B涨超8%，和铂医药-B涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114259311","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114259311?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:04","pubTimestamp":1767837899,"startTime":"0","endTime":"0","summary":"1月8日，港股医药股走高，$加科思-B$涨超8%，$和铂医药-B$涨超7%，$映恩生物-B$、$复宏汉霖$涨超5%。消息面上，1月7日，从国家药监局获悉，为加快临床急需境外已上市药品在境内上市，满足患者临床用药迫切需求，国家药监局进一步优化这类药品审评审批。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d251f2ebc5960a6f1c440ec4608735f3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167","BK1161","BK1515","02142","BK1574","BK1583","159938","09939"],"gpt_icon":0},{"id":"2601333598","title":"每日卖空追踪 | 和铂医药-B 01月07日卖空量成交19.3万股，卖空比例为2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601333598","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601333598?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774628,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月07日，涨8.24%，卖空量成交19.3万股，较上一交易日减少73.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163408a4a6e640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163408a4a6e640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2601333514","title":"和铂医药-B盘中异动 临近午盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601333514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601333514?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:36","pubTimestamp":1767757015,"startTime":"0","endTime":"0","summary":"2026年01月07日临近午盘11时36分，和铂医药-B股票出现波动，股价急速拉升5.06%。截至发稿，该股报12.880港元/股，成交量296.7万股，换手率0.34%，振幅5.14%。和铂医药-B股票所在的生物技术行业中，整体涨幅为3.59%。其相关个股中，中国抗体-B、轩竹生物-B、同源康医药-B涨幅较大，振幅较大的相关个股有轩竹生物-B、中国抗体-B、中生北控生物科技，振幅分别为16.22%、16.20%、11.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107113655a4a5d93b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107113655a4a5d93b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2601828016","title":"港股异动 | 和铂医药-B(02142)涨超3% 与长海医院联合申报的攻坚胰腺癌项目获国家科技创新重大专项立项","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828016","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601828016?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:55","pubTimestamp":1767754559,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B涨超3%，截至发稿，涨3.34%，报12.67港元，成交额3048.05万港元。消息面上，1月7日，据和铂医药官微消息，近日，国家科技创新2030“癌症、心脑血管、呼吸和代谢性疾病防治研究”重大专项2025年度立项结果正式公布。由上海长海医院牵头，和铂医药参与联合申报的 “胰腺癌发病机制和临床精准诊治新范式研究” 项目成功获批立项。据介绍，和铂医药始终专注于肿瘤及免疫性疾病领域创新抗体疗法的研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2601847539","title":"中金：维持和铂医药-B(02142) 跑赢行业评级 上调目标价至18港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601847539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601847539?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:30","pubTimestamp":1767749422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，由于和铂医药-B BD首付款增厚收入，上调2026年盈利预测228%至0.62亿美元，并首次引入2027年盈利预测0.60亿美元。该行维持跑赢行业评级，基于DCF估值，由于上调盈利预测，该行上调目标价34.3%至18.00港元，较当前股价有44.5%上行空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142"],"gpt_icon":0},{"id":"1111880793","title":"和铂医药（02142）12月股份变动月报：净减少775,000股已发行股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1111880793","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111880793?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:42","pubTimestamp":1767688963,"startTime":"0","endTime":"0","summary":"2026年1月6日，和铂医药控股有限公司披露截至2025年12月31日的股份变动月报。报告显示，该公司法定注册资本维持20,000,000,000股，面值每股USD0.000025，总额USD500,000，月内未发生任何变动。截至2025年11月30日，公司已发行股份为869,456,522股，库存股份为24,337,000股，合计893,793,522股。12月内，已发行股份净减少775,000股，库存股份增加1,100,000股，期末数据分别为868,681,522股与25,437,000股，共计894,118,522股。另根据多次购回安排，共计1,100,000股转为库存股份，另有406,000股处于拟注销但截至月末尚未注销状态。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"2601685873","title":"每日卖空追踪 | 和铂医药-B 01月05日卖空量成交17.4万股，卖空比例为3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601685873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601685873?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601827,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月05日，涨3.15%，卖空量成交17.4万股，较上一交易日减少71.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163552a6f52504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163552a6f52504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1161","BK1583"],"gpt_icon":0},{"id":"2601719858","title":"和铂医药-B01月05日主力净流入32.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601719858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601719858?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600944,"startTime":"0","endTime":"0","summary":"01月05日, 和铂医药-B股价涨3.15%，报收12.46元，成交金额6373.7万元，换手率0.59%，振幅5.63%，量比0.95。和铂医药-B今日主力资金净流入32.0万元，上一交易日主力净流出58.8万元。该股近5个交易日下跌3.61%，主力资金累计净流出373.6万元；近20日主力资金累计净流入3704.9万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162007a49e1646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162007a49e1646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2600764050","title":"和铂医药-B(02142.HK)1月2日耗资601.3万港元回购50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2600764050","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600764050?lang=zh_cn&edition=full","pubTime":"2026-01-02 19:07","pubTimestamp":1767352024,"startTime":"0","endTime":"0","summary":"格隆汇1月2日丨和铂医药-B(02142.HK)发布公告，2026年1月2日耗资601.3万港元回购50万股，回购价格每股11.78-12.12港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260102/31911273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","02142","BK1161","BK1574"],"gpt_icon":0},{"id":"1189902433","title":"和铂医药（02142）更新翌日披露报表，回购10万股股份，涉资约121.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189902433","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189902433?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:37","pubTimestamp":1767343076,"startTime":"0","endTime":"0","summary":"和铂医药控股有限公司于2026年1月2日刊发翌日披露报表。公告显示，公司于2025年12月31日在香港联合交易所回购10万股普通股，回购价格区间为每股12.12港元至12.29港元，总金额约121.94万港元。根据公告，本次回购后，公司已发行股份数目减少至868,681,522股，库藏股数量增至25,437,000股，两者合计894,118,522股。本次回购完成后，公司将于2026年1月31日前暂不发行新股或处置库藏股份。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22320a8917eb1e51107425f2dd59eadf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0897},{"period":"1month","weight":0.1377},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.6085},{"period":"1year","weight":4.4566},{"period":"ytd","weight":0.1891}],"compareEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.0429},{"period":"6month","weight":0.0876},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.0534}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品主要包括巴托利单抗（HBM9161）、HBM9378、HBM7020、TCE Program、普鲁苏拜单抗（HBM4003）以及HBM7022等。该公司产品主要用于治疗全身型重症肌无力（gMG）、慢性阻塞性肺病（COPD）、哮喘、自身免疫疾病、黑色素瘤、结直肠癌以及实体瘤等。该公司通过专有抗体技术平台“Harbour Mice”、“HBICE”、“HBICA”及单克隆B细胞筛选平台提供下一代抗体以及生物解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.118465},{"month":2,"riseRate":0.2,"avgChangeRate":-0.004171},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.266929}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}